C12ORF48 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.958600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.875400E-01
Normal-vs-Stage2
6.257400E-01
Normal-vs-Stage3
7.107600E-01
Normal-vs-Stage4
7.483800E-01
Stage1-vs-Stage2
4.816400E-01
Stage1-vs-Stage3
7.837400E-01
Stage1-vs-Stage4
7.529200E-01
Stage2-vs-Stage3
3.630800E-01
Stage2-vs-Stage4
8.606000E-01
Stage3-vs-Stage4
5.137400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.770600E-01
Normal-vs-AfricanAmerican
8.288200E-01
Normal-vs-Asian
9.194800E-01
Caucasian-vs-AfricanAmerican
7.066600E-01
Caucasian-vs-Asian
3.444600E-01
AfricanAmerican-vs-Asian
7.110400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.938800E-01
Normal-vs-Female
6.926800E-01
Male-vs-Female
8.948200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.064800E-01
Normal-vs-Age(41-60Yrs)
6.251200E-01
Normal-vs-Age(61-80Yrs)
7.219200E-01
Normal-vs-Age(81-100Yrs)
5.863800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.284000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.990640E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.054410E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.171000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.777600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.629000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.156800E-01
Normal-vs-Daily Drinker
7.854800E-01
Normal-vs-Weekly Drinker
6.982000E-01
Normal-vs-Occasional Drinker
6.978600E-01
Normal-vs-Social Drinker
6.354000E-01
Non Drinker-vs-Daily Drinker
9.018400E-01
Non Drinker-vs-Weekly Drinker
5.698400E-01
Non Drinker-vs-Occasional Drinker
6.311200E-01
Non Drinker-vs-Social Drinker
5.624000E-01
Daily Drinker-vs-Weekly Drinker
6.226200E-01
Daily Drinker-vs-Occasional Drinker
7.372200E-01
Daily Drinker-vs-Social Drinker
6.686000E-01
Weekly Drinker-vs-Occasional Drinker
7.811200E-01
Weekly Drinker-vs-Social Drinker
8.317600E-01
Occasional Drinker-vs-Social Drinker
9.373000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.988200E-01
Normal-vs-Grade 2
6.486800E-01
Normal-vs-Grade 3
6.662800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.672160E-02
Grade 1-vs-Grade 3
1.037760E-02
Grade 1-vs-Grade 4
5.988200E-01
Grade 2-vs-Grade 3
3.896400E-01
Grade 2-vs-Grade 4
6.486800E-01
Grade 3-vs-Grade 4
6.662800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.728600E-01
Normal-vs-NonDiabetic
6.995800E-01
Diabetic-vs-NonDiabetic
2.417800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.050800E-01
Normal-vs-NoPancreatitis
7.219600E-01
Pancreatitis-vs-NoPancreatitis
5.110800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.501400E-01
Normal-vs-N1
6.238000E-01
N0-vs-N1
2.135800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.093800E-01
Normal-vs-TP53-NonMutant
8.154400E-01
TP53-Mutant-vs-TP53-NonMutant
1.655190E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
